Prevalence and Risk Factors of Hyperkalemia in Non-Dialysis Chronic Kidney Disease Patients in Community
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorXiujuan Zang
About this trial
The goal of this observational study is to investigate the prevalence and risk factors of hyperkalemia in community-based non-dialysis chronic kidney disease (CKD) patients. The main questions it aims to answer are:
1. What is the prevalence of hyperkalemia in non-dialysis CKD patients in a primary care setting? 2. What are the key risk factors influencing the occurrence of hyperkalemia in this population? Researchers will collect clinical and demographic data from participants across 18 community health centers and use both point-of-care testing (POCT) and laboratory-based methods to measure serum potassium levels and related parameters.
Participants will:
1. Provide blood samples for POCT and laboratory testing. 2. Participate in interviews or questionnaires to gather clinical and lifestyle information.
The findings will be used to construct a risk prediction model for hyperkalemia, aiming to optimize screening pathways and improve disease management strategies in primary care.
Eligibility criteria
Qualifiers
Body temperature: 36.0°C-38.0°C;
Pulse: 50-120 beats/min;
Respiratory rate: 10-24 breaths/min;
Blood pressure: Systolic blood pressure ≥90 mmHg and diastolic blood pressure ≥60 mmHg.
Disqualifiers
Patients in the unstable phase of acute cardiovascular or cerebrovascular diseases (e.g., acute cerebral infarction, cerebral hemorrhage, or acute coronary syndrome).
Patients in the unstable phase of severe acute diabetic complications (e.g., diabetic ketoacidosis or hyperosmolar hyperglycemic coma).
Patients currently in the acute kidney injury (AKI) stage.
Patients who have started renal replacement therapy.
Trial design
Treatments tested in this trial
- No Intervention
Treatment groups
No treatment groups listed
Sponsors and collaborators
Xiujuan Zang
Lead sponsor
Songjiang Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Sponsor institution
Source ClinicalTrials.gov